新瘤基因中的一个点突变模仿了受体聚合的连接体诱导
1Department of Pathology, University of Pennsylvania, Philadelphia 19104-6082.
Nature
|May 18, 1989
概括
致癌性neu基因产物p185neu在细胞膜上形成聚合物,与其非致癌性对应物p185c-neu不同. 这种聚合会增加氨酸激酶活性,推动细胞转化.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 细胞信号传递 细胞信号传递
背景情况:
- 鼠 neu 基因编码了一种类似于表皮生长因子受体的蛋白质,作为原型瘤基因起作用.
- 一个点突变可以将neu基因转化为瘤基因,导致产生瘤蛋白 (p185neu),而其正常对应物 (p185c-neu) 是非瘤基因.
- 这两种蛋白质都与氨酸激酶生长因子受体具有共同的结构特征,包括细胞外氨酸丰富的域,一个跨膜区域和一个细胞内氨酸激酶域.
研究的目的:
- 研究致癌蛋白p185neu与非致癌蛋白p185c-neu之间的结构和功能差异.
- 了解为什么突变的neu基因产物 (p185neu) 是致癌的,而正常的产物 (p185c-neu) 不是.
- 探索蛋白质聚合在p185neu.的致癌活性中的作用.
主要方法:
- 对新基因产品的比较分析,p185neu和p185c-neu.
- 在p185neu的跨膜区域中对氨基酸替代的研究 (氨酸到谷氨酸在664位).
- 评估p185neu和p185c-neu在等离子体膜上的结合状态 (聚合).
主要成果:
- 致癌的p185neu蛋白与p185c-neu的区别在于,在跨膜区域中单个氨基酸的替代 (氨酸到谷氨酸).
- 这种替代增强了p185neu的内在氨酸激酶活性,与细胞转化相关.
- p185neu主要以聚合形式在血上组织,而p185c-neu则没有.
结论:
- 血膜上的p185neu的聚合是其致癌潜力的关键因素.
- 这种聚合可能模仿联体诱导的受体聚合,导致持续的酶激活和细胞转化.
- 针对p185neu的聚合状态可能是针对由neu瘤基因驱动的癌症的治疗策略.
相关概念视频
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...


